Activation of the pyrin inflammasome through the RhoA signaling pathway in FMF and HIDS by YH Park et al.
ORAL PRESENTATION Open Access
Activation of the pyrin inflammasome through
the RhoA signaling pathway in FMF and HIDS
YH Park, D Kastner, JJ Chae*
From 8th International Congress of Familial Mediterranean Fever and Systemic Autoinflammatory Diseases
Dresden, Germany. 30 September - 3 October 2015
Introduction
Mutations in the genes encoding pyrin and mevalonate
kinase (MVK) cause the autoinflammatory diseases
familial Mediterranean fever (FMF) and hyperimmuno-
globulinemia D syndrome (HIDS), respectively. The
inflammation of both diseases is mediated by interleu-
kin-1b (IL-1b). Recently it has been reported that pyrin
forms an inflammasome, a multiprotein complex that
mediates the maturation of IL-1b by activating caspase-
1, in response to bacterial modifications of RhoA. How-
ever, the precise molecular mechanism by which the
pyrin inflammasome is activated is unknown.
Objectives
To investigate the molecular mechanism of pyrin
inflammasome activation and the molecular pathogen-
esis of FMF and HIDS.
Methods
We studied IL-1b production in immune cells from wild
type mice and from several knockout and knockin
mouse strains, as well as from FMF and HIDS patients
and healthy controls, in response to LPS and/or various
other bacterial toxins, and in the presence of pharmaco-
logic agents targeting the Rho GTPase or adenylate
cyclase pathways. Protein interactions were studied by
immunoprecipitation.
Results
The Clostridial TcdB and C3 toxins, which inactivate
RhoA, activate IL-1b maturation by a pathway that is
Mefv-, Asc-, and Caspase-1-dependent, but Nlrp3-,
Nlrc4-, and Aim2-independent. Leukocytes from FMF
patients or FMF knockin mice produce IL-1b in
response to LPS without a second signal; this is inhibited
both by the bacterial CNF toxin, which activates RhoA,
and by colchicine. In addition, the constitutive IL-1b
secretion from FMF patients’ peripheral blood mononuc-
lear cells (PBMCs) or macrophages of FMF-KI mice is
potentiated by cAMP, which has a role in suppressing
RhoA through PKA-mediated direct phosphorylation.
RhoA inhibition-induced inflammasome activation
is mediated by reduced activities of downstream RhoA-
effector kinases, Rho-associated coiled-coil-containing
protein kinase (ROCK) and protein kinase N1 (PKN1).
Indeed, the kinase domain of the RhoA-effector kinases
binds to pyrin directly and phosphorylates two serine resi-
dues (S208 and S242 of human pyrin). The phosphory-
lated pyrin is recognized by 14-3-3 proteins, which
negatively regulate the pyrin inflammasome. The binding
affinity of 14-3-3 proteins for the pyrin of FMF-KI mice is
substantially lower than for wild-type mouse pyrin, which
lacks a B30.2 orthologous domain. The constitutive IL-1b
secretion from macrophages of FMF-KI mice as well as
FMF or HIDS patients’ PBMCs is attenuated by activating
RhoA-effector kinases. Defects in prenylation, seen in
HIDS, lead to RhoA inactivation and consequent pyrin
inflammasome activation.
Conclusion
These data directly implicate Rho GTPase in the regula-
tion of the pyrin inflammasome, and suggest that this
pathway is also important in HIDS.
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